41 results
8-K
EX-10.1
COGT
Cogent Biosciences Inc
14 Feb 24
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
8:35am
Act and the rules and regulations promulgated by the Commission and the Public Accounting Oversight Board thereunder.
(j) Absence of Certain Changes
8-K
EX-1.1
36e6xy 5t5t6vu9axka5
8 Jun 23
Entry into a Material Definitive Agreement
4:31pm
8-K/A
EX-1.1
3q5jj2b8nj09 9ljy
16 Jun 22
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-1.1
udx9y
15 Jun 22
Entry into a Material Definitive Agreement
5:18pm
8-K
EX-10.1
kslt8rrblofi fdp
9 Jul 21
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-1.1
2s04xkgov0p 2i3h
2 Dec 20
Entry into a Material Definitive Agreement
5:08pm
424B5
198xlhus
2 Dec 20
Prospectus supplement for primary offering
5:06pm